SG11201504300VA - Accelerated prediction of cancer progression and response to treatment - Google Patents
Accelerated prediction of cancer progression and response to treatmentInfo
- Publication number
- SG11201504300VA SG11201504300VA SG11201504300VA SG11201504300VA SG11201504300VA SG 11201504300V A SG11201504300V A SG 11201504300VA SG 11201504300V A SG11201504300V A SG 11201504300VA SG 11201504300V A SG11201504300V A SG 11201504300VA SG 11201504300V A SG11201504300V A SG 11201504300VA
- Authority
- SG
- Singapore
- Prior art keywords
- response
- treatment
- cancer progression
- prediction
- accelerated
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261732375P | 2012-12-02 | 2012-12-02 | |
PCT/IB2013/060580 WO2014083555A1 (en) | 2012-12-02 | 2013-12-02 | Accelerated prediction of cancer progression and response to treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201504300VA true SG11201504300VA (en) | 2015-07-30 |
Family
ID=50827252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201504300VA SG11201504300VA (en) | 2012-12-02 | 2013-12-02 | Accelerated prediction of cancer progression and response to treatment |
Country Status (7)
Country | Link |
---|---|
US (1) | US10760060B2 (en) |
EP (1) | EP2925890A4 (en) |
JP (1) | JP6430392B2 (en) |
CN (1) | CN105121657A (en) |
CA (1) | CA2893549C (en) |
SG (1) | SG11201504300VA (en) |
WO (1) | WO2014083555A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016077692A1 (en) * | 2014-11-14 | 2016-05-19 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Apparatus, kit and method for manipulating small model organisms |
US20170370709A1 (en) * | 2015-06-08 | 2017-12-28 | Trustees Of Tufts College | Imaging System To Characterize Dynamic Changes In Cell And Particle Characteristics |
US10453551B2 (en) | 2016-06-08 | 2019-10-22 | X Development Llc | Simulating living cell in silico |
WO2018063098A1 (en) * | 2016-09-30 | 2018-04-05 | Nanyang Technological University | Apparatus for embryo biopsy |
EP3542290B1 (en) * | 2016-11-17 | 2024-01-03 | NantBio, Inc. | Validation of inferred anticancer pathways |
GB201710955D0 (en) | 2017-07-07 | 2017-08-23 | Insphero Ag | Microtissue compartment device |
KR101965299B1 (en) * | 2017-11-14 | 2019-04-03 | 주식회사 수젠텍 | Assembly type blot strip device |
CN110402853B (en) * | 2018-04-28 | 2022-01-07 | 义慧科技(深圳)有限公司 | Detection model for tumor killing ability of immune cells and construction method and application thereof |
CN108841869B (en) * | 2018-05-31 | 2022-05-06 | 上海交通大学医学院附属瑞金医院 | Construction method and application of zebra fish NK/TCL tumor model |
CN112094890A (en) * | 2019-06-17 | 2020-12-18 | 南京尧顺禹生物科技有限公司 | Method for quantitatively evaluating proliferation of tumor cells transplanted into zebra fish embryo |
US20210251183A1 (en) * | 2020-02-03 | 2021-08-19 | Korea Research Institute Of Standards And Science | Monitoring method of heart rate for toxicity test using high-speed digital holography |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2286908T3 (en) * | 1998-12-01 | 2007-12-01 | Phylonix Pharmaceuticals Inc. | METHODS TO ENTER HETEROLOGICAL CELLS IN FISH. |
AU4487900A (en) | 1999-04-23 | 2000-11-10 | Monica Palacios-Boyce | Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof |
AU2002246527A1 (en) | 2000-11-28 | 2002-08-06 | Georgetown University | Cell transformation using a single chip silicon microfabricated array incorporating integrated micro-piercing injectors |
US20020116732A1 (en) | 2001-02-13 | 2002-08-22 | Leandro Christmann | Microinjection assembly and methods for microinjecting and reimplanting avian eggs |
US7339090B2 (en) | 2001-02-13 | 2008-03-04 | Avigenics, Inc. | Microinjection devices and methods of use |
US7190449B2 (en) | 2002-10-28 | 2007-03-13 | Nanopoint, Inc. | Cell tray |
US20050112030A1 (en) | 2003-08-21 | 2005-05-26 | Gaus Stephanie E. | Meshwell plates |
US20080077999A1 (en) * | 2004-03-23 | 2008-03-27 | Eisai R&D Management Co., Ltd. | Using Nonhuman Animal Model, Method of Measuring Transcription Activity Method of Measuring Cell Quantity and Method of Measuring Tumor Volume |
ES2259566B1 (en) | 2005-03-29 | 2007-08-01 | Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria-Inia | SUPPLEMENTATION FOR EMBRYO HANDLING AND / OR CELLULAR MEDIA. |
EP2329817A1 (en) * | 2009-09-04 | 2011-06-08 | Ernst-Moritz-Arndt-Universität Greifswald | Retinoic acid receptor antagonists, miR-10a inhibitors and inhibitors of HOXB1 or HOXB3 repressors for treating pancreatic cancer |
GB2479521A (en) | 2010-03-19 | 2011-10-19 | Univ Leiden | Array microinjection apparatus and methods for single cells or embryos |
-
2013
- 2013-12-02 CN CN201380070892.6A patent/CN105121657A/en active Pending
- 2013-12-02 WO PCT/IB2013/060580 patent/WO2014083555A1/en active Application Filing
- 2013-12-02 CA CA2893549A patent/CA2893549C/en active Active
- 2013-12-02 SG SG11201504300VA patent/SG11201504300VA/en unknown
- 2013-12-02 EP EP13859257.1A patent/EP2925890A4/en active Pending
- 2013-12-02 JP JP2015544609A patent/JP6430392B2/en active Active
- 2013-12-02 US US14/649,196 patent/US10760060B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016501021A (en) | 2016-01-18 |
WO2014083555A1 (en) | 2014-06-05 |
EP2925890A1 (en) | 2015-10-07 |
CA2893549A1 (en) | 2014-06-05 |
EP2925890A4 (en) | 2016-06-01 |
CN105121657A (en) | 2015-12-02 |
JP6430392B2 (en) | 2018-11-28 |
CA2893549C (en) | 2023-05-09 |
US20150315546A1 (en) | 2015-11-05 |
US10760060B2 (en) | 2020-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288181A (en) | Methods of treating cancer | |
SG11201504300VA (en) | Accelerated prediction of cancer progression and response to treatment | |
HK1214128A1 (en) | Treatment of cancer | |
HK1205254A1 (en) | Methods of treatment of cancer | |
EP2685823A4 (en) | Treatment of cancer | |
GB201217892D0 (en) | Treatment of cancer | |
HK1204956A1 (en) | Treatment of cancer | |
SI2892925T1 (en) | Combination treatment of cancer | |
GB201403083D0 (en) | Treatment of cancer | |
EP2928456A4 (en) | Methods and compositions for treatment of cancer | |
HK1232118A1 (en) | Treatment of cancer | |
EP2709730A4 (en) | Treatment and prognosis of cancer | |
SG11201504779YA (en) | Methods and compositions relating to treatment of cancer | |
GB201217890D0 (en) | Treatment of cancer | |
GB201113140D0 (en) | Prediction and treatment of cancer | |
GB201208296D0 (en) | Treatment of cancer | |
GB201222949D0 (en) | Combination Treatment of Cancer | |
GB201222950D0 (en) | Combination treatment of cancer | |
GB201202081D0 (en) | Prevention and/or treatment of cancer and/or cancer metastasis | |
GB201322347D0 (en) | Treatment of cancer | |
GB201221118D0 (en) | Methods of treatment | |
GB201317373D0 (en) | Treatment and prevention of cancer | |
GB201216740D0 (en) | Methods of treatment | |
GB201216748D0 (en) | Methods of treatment | |
GB201318742D0 (en) | Treatment of cancer |